Testing effectiveness (Phase 2)Study completedNCT00507767
What this trial is testing
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more
National Cancer Institute (NCI) 15